Načítá se...
Anti-Inflammatory Drugs Reduce the Risk of Hepatocellular Carcinoma Development
Nowadays, patients with chronic hepatitis C in all countries are generally treated with interferon (IFN), and more than 50% of patients become HCV-RNA negative following PEG-IFN plus ribavirin therapy, but unfortunately, the IFN therapy is not effective in about 70% of patients with HCV-associated L...
Uloženo v:
| Hlavní autoři: | , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
International Scholarly Research Network
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3195877/ https://ncbi.nlm.nih.gov/pubmed/22084728 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5402/2011/390676 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|